The Scientist

» European Medicines Agency

Most Recent

image: Brexit’s Effects on Science

Brexit’s Effects on Science

By | June 24, 2016

Researchers raise concerns related to collaboration, funding, and regulatory decisions.

0 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: EU Considers Curbing Antibiotic Use

EU Considers Curbing Antibiotic Use

By | July 30, 2013

The European Medicines Agency has recommended that farmers stop using the antibiotic colistin prophylactically, citing human health concerns.

0 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: Restoring Hidden Clinical Data

Restoring Hidden Clinical Data

By | June 18, 2013

Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.  

0 Comments

image: Release of Drug Data Blocked

Release of Drug Data Blocked

By | May 2, 2013

A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.

0 Comments

image: Gene Therapy Arrives in Europe

Gene Therapy Arrives in Europe

By | November 6, 2012

The European Commission approves the Western hemisphere’s first gene therapy, aimed at correcting a lipid-processing disorder.

7 Comments

image: US Drug Approvals Top Canada, Europe

US Drug Approvals Top Canada, Europe

By | May 18, 2012

The FDA approves drugs faster and earlier than regulatory agencies in other countries.

3 Comments

image: Europe Watches Conflicts of Interest

Europe Watches Conflicts of Interest

By | April 5, 2012

The European Medicines Agency revised its policy on conflicts of interest in response to concerns regarding its ability to conduct independent evaluations.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham